| Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease SH Ranganath, O Levy, MS Inamdar, JM Karp Cell stem cell 10 (3), 244-258, 2012 | 900 | 2012 |
| Engineering stem cell organoids X Yin, BE Mead, H Safaee, R Langer, JM Karp, O Levy Cell stem cell 18 (1), 25-38, 2016 | 782 | 2016 |
| Nanowired three-dimensional cardiac patches T Dvir, BP Timko, MD Brigham, SR Naik, SS Karajanagi, O Levy, H Jin, ... Nature nanotechnology 6 (11), 720-725, 2011 | 781 | 2011 |
| A complex human gut microbiome cultured in an anaerobic intestine-on-a-chip S Jalili-Firoozinezhad, FS Gazzaniga, EL Calamari, DM Camacho, ... Nature biomedical engineering 3 (7), 520-531, 2019 | 580 | 2019 |
| Shattering barriers toward clinically meaningful MSC therapies O Levy, R Kuai, EMJ Siren, D Bhere, Y Milton, N Nissar, M De Biasio, ... Science advances 6 (30), eaba6884, 2020 | 441 | 2020 |
| Human organ chip models recapitulate orthotopic lung cancer growth, therapeutic responses, and tumor dormancy in vitro BA Hassell, G Goyal, E Lee, A Sontheimer-Phelps, O Levy, CS Chen, ... Cell reports 21 (2), 508-516, 2017 | 414 | 2017 |
| Prevascularization of cardiac patch on the omentum improves its therapeutic outcome T Dvir, A Kedem, E Ruvinov, O Levy, I Freeman, N Landa, R Holbova, ... Proceedings of the National Academy of Sciences 106 (35), 14990-14995, 2009 | 398 | 2009 |
| Quantitative prediction of human pharmacokinetic responses to drugs via fluidically coupled vascularized organ chips A Herland, BM Maoz, D Das, MR Somayaji, R Prantil-Baun, R Novak, ... Nature biomedical engineering 4 (4), 421-436, 2020 | 301 | 2020 |
| Robotic fluidic coupling and interrogation of multiple vascularized organ chips R Novak, M Ingram, S Marquez, D Das, A Delahanty, A Herland, BM Maoz, ... Nature biomedical engineering 4 (4), 407-420, 2020 | 290 | 2020 |
| On-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiology DB Chou, V Frismantas, Y Milton, R David, P Pop-Damkov, D Ferguson, ... Nature biomedical engineering 4 (4), 394-406, 2020 | 213 | 2020 |
| mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation O Levy, W Zhao, LJ Mortensen, S LeBlanc, K Tsang, M Fu, JA Phillips, ... Blood, The Journal of the American Society of Hematology 122 (14), e23-e32, 2013 | 213 | 2013 |
| Towards an arthritis flare-responsive drug delivery system N Joshi, J Yan, S Levy, S Bhagchandani, KV Slaughter, NE Sherman, ... Nature Communications 9 (1), 1275, 2018 | 199 | 2018 |
| Modeling radiation injury-induced cell death and countermeasure drug responses in a human Gut-on-a-Chip S Jalili-Firoozinezhad, R Prantil-Baun, A Jiang, R Potla, T Mammoto, ... Cell death & disease 9 (2), 223, 2018 | 169 | 2018 |
| Human colon-on-a-chip enables continuous in vitro analysis of colon mucus layer accumulation and physiology A Sontheimer-Phelps, DB Chou, A Tovaglieri, TC Ferrante, T Duckworth, ... Cellular and molecular gastroenterology and hepatology 9 (3), 507-526, 2020 | 162 | 2020 |
| Activation of the ERK1/2 cascade via pulsatile interstitial fluid flow promotes cardiac tissue assembly T Dvir, O Levy, M Shachar, Y Granot, S Cohen Tissue engineering 13 (9), 2185-2193, 2007 | 113 | 2007 |
| Application of biomaterials to advance induced pluripotent stem cell research and therapy Z Tong, A Solanki, A Hamilos, O Levy, K Wen, X Yin, JM Karp The EMBO journal 34 (8), 987-1008, 2015 | 104 | 2015 |
| Functional inactivation of p53 by human T-cell leukemia virus type 1 Tax protein: mechanisms and clinical implications Y Tabakin-Fix, I Azran, Y Schavinky-Khrapunsky, O Levy, M Aboud Carcinogenesis 27 (4), 673-681, 2006 | 97 | 2006 |
| Performance-enhanced mesenchymal stem cells via intracellular delivery of steroids JA Ankrum, RG Dastidar, JF Ong, O Levy, JM Karp Scientific reports 4 (1), 4645, 2014 | 95 | 2014 |
| A prodrug-doped cellular Trojan Horse for the potential treatment of prostate cancer O Levy, WN Brennen, E Han, DM Rosen, J Musabeyezu, H Safaee, ... Biomaterials 91, 140-150, 2016 | 73 | 2016 |
| A phase I study to assess the safety and cancer-homing ability of allogeneic bone marrow-derived mesenchymal stem cells in men with localized prostate cancer MT Schweizer, H Wang, TJ Bivalacqua, AW Partin, SJ Lim, C Chapman, ... Stem cells translational medicine 8 (5), 441-449, 2019 | 59 | 2019 |
